Orikine Bio
Ariadna Montero-Blay is a biotechnology expert and entrepreneur with significant experience in the field. As Co-Founder and Head of Biology at Orikine Bio since September 2022, Ariadna leads a team focused on developing engineered cytokines to transform the treatment of immune-mediated diseases. Previously, Ariadna served on the Board of Directors at the Centre for Genomic Regulation from September 2017 to September 2022 and held various research positions, including Postdoctoral Researcher and PhD Candidate. Educational credentials include a Doctor of Philosophy in Biomedicine from Universitat Pompeu Fabra and Executive MBA from Esade, among others.
This person is not in any teams
Orikine Bio
Orikine Bio is a pioneering biotech company dedicated to advancing the field of engineered cytokines with unparalleled biological features for the treatment of immune-mediated diseases. Our core mission is to unlock the untapped potential of cytokines, enabling us to offer transformative therapies that have the power to reshape the lives of patients around the globe.